Drug firm Lupin on Friday said its subsidiary has acquired nine brands from the Medical Nutritional Institute SA (MNI) in South Africa, through a partnership deal with ImpiloVest. Pharma Dynamics has acquired the nine brands along with their associated trademarks through a partnership deal with ImpiloVest, a South African investment firm, Lupin said in a statement.

制药公司Lupin周五表示，其子公司已通过与ImpiloVest的合作协议，从南非医学营养研究所（MNI）收购了9个品牌。Lupin在一份声明中表示，Pharma Dynamics通过与南非投资公司ImpiloVest的合作协议收购了这九个品牌及其相关商标。

The acquired brands include AntaGolin, RyChol, NeuroVance, SkinVance, FlamLeve, Rheumalin, SleepVance, ImmunoVance, and OviVance, it added. These products cater to a range of health issues such as metabolic syndrome, insulin resistance, cognitive function, skin health, inflammation, joint care, sleep quality, immune support, and women's hormonal well-being.

收购的品牌包括AntaGolin、RyChol、NeuroVance、SkinVance、FlamLeve、Rheumalin、SleepVance、ImmunoVance和OviVance，它补充道。这些产品迎合了一系列健康问题，如代谢综合征、胰岛素抵抗、认知功能、皮肤健康、炎症、关节护理、睡眠质量、免疫支持和女性荷尔蒙健康。

'This acquisition is a major step for Lupin to expand our footprint in the complementary and alternative medicines sector,' Lupin President EMEA Thierry Volle said. MNI's innovative plant-based products align perfectly with company's goal to provide holistic and sustainable healthcare solutions to patients in South Africa, he added.

“此次收购是卢平扩大在补充和替代药物领域足迹的重要一步，”卢平总裁EMEA Thierry Volle说。他补充说，MNI的创新植物产品与该公司为南非患者提供全面和可持续的医疗保健解决方案的目标完全一致。

Lupin shares on Friday ended 0.65 per cent up at Rs 2,197.60 apiece on the BSE.(You can now subscribe to our Economic Times WhatsApp channel)(You can now subscribe to our Economic Times WhatsApp channel).

卢平股价周五在BSE指数上涨0.65%，收于每股2197.60卢比。（您现在可以订阅我们的经济时报WhatsApp频道）（您现在可以订阅我们的经济时报WhatsApp频道）。